CANADIAN AMYLOIDOSIS SOCIETY (CAS) WEBSITE - ALL CONTENT TEXT
================================================================

This document contains all text content used across the Canadian Amyloidosis Society website, organized by pages and sections.

** CONTENT CLEANED (July 25, 2025) **
✅ Removed all color codes, gradients, and hex values
✅ Removed all icon references and technical formatting
✅ Removed all internal links and navigation paths
✅ Kept only essential text content for documentation
✅ Maintained section structure and content organization

================================================================================
1. HOMEPAGE (/)
================================================================================

--- HERO SECTION ---
Badge: Clinical Excellence Platform
Main Title: Canadian Amyloidosis Society
Subtitle: Advancing evidence-based amyloidosis care through clinical excellence, professional collaboration, and structured knowledge sharing.

Title Structure:
- Line 1: "Canadian"
- Line 2: "Amyloidosis"  
- Line 3: "Society"

Clinical Impact Metrics (3 cards):
- 6-Week Diagnosis: "Reduced diagnostic timeline"
- 25+ Centers: "Network coverage"  
- 1,200+ Patients: "Served annually"

Quick Action Tiles (2x2 grid):
- Join
- Directory
- Upload
- Learn

--- WELCOME SECTION ---
Badge: Who we are
Title: Welcome to the Canadian Amyloidosis Society (CAS)
Subtitle: Your trusted partner in amyloidosis care, connecting patients, families, and healthcare professionals across Canada.

Main Description: We are dedicated to improving the lives of those affected by amyloidosis through education, support, and advocacy. Our comprehensive platform provides essential resources, connects you with specialized care, and builds a supportive community for patients and families nationwide.

Layout: Two-column grid with content left, image right

Left Column Content:
- Premium badge
- Heading text
- Two paragraphs of description text
- Call-to-action button

Right Column:
- Medical professional image in rounded container
- Stats overlay on bottom of image with mission/vision

Stats Overlay on Image (3 columns with dividers):
Left: "15+" | "Years Supporting"
Center: "1K+" | "Patients Helped"  
Right: "100%" | "Patient Focused"

Button: "Learn More About Our Work" 

--- ABOUT AMYLOIDOSIS SECTION ---
Badge: Medical Information
Title: What is Amyloidosis?
Subtitle: Amyloidosis is a rare disease with life-altering consequences—but early detection can dramatically improve outcomes. The Canadian Amyloidosis Society is building a trusted national hub for clinicians, researchers, and families seeking answers.

Layout: Title section, then 4-column grid of type cards, then large Early Detection section below

Type Cards (4 cards in grid):
Each card has: name, description, prevalence

1. AL Amyloidosis 
   - 
   - Description: Most common form, affects heart, kidneys, liver, and nervous system
   - Prevalence: 70% of cases

2. AA Amyloidosis
   - 
   - Description: Secondary to chronic inflammatory conditions
   - Prevalence: 20% of cases

3. Hereditary
   - 
   - Description: Genetic forms including TTR, fibrinogen, and lysozyme
   - Prevalence: 5% of cases

4. Other Types
   - 
   - Description: Including β2-microglobulin and localized forms
   - Prevalence: 5% of cases

Early Detection Section (large 2-column card):
Background: White/transparent backdrop with medical pattern overlay

Left Column:
- Title: "Early Detection Saves Lives" (
- Description: Amyloidosis is often misdiagnosed or diagnosed late because its symptoms mimic other conditions. Early recognition and proper testing are crucial for better patient outcomes.
- Subdescription: Our directory connects patients with specialized centers and healthcare providers experienced in diagnosing and treating amyloidosis across Canada.
- Button: "Learn More" 

Right Column (2 hoverable statistics cards):
1. Card with  
   - "2-3 years" (large 
   - "Average time to diagnosis" (bold title)
   - "Many patients see multiple doctors before receiving proper diagnosis" (description)

2. Card with  
   - "3,000+" (large 
   - "Canadians affected" (bold title)
   - "Estimated number of people living with amyloidosis in Canada" (description)

--- QUICK LINKS SECTION ---
Badge: Quick Access
Title: Essential Resources
Subtitle: Quick access to the most important tools and information for patients, families, and healthcare professionals.

6-Card Grid Layout:
Each card has: icon, title, description, brand 

1. Find Specialists Card:
   - 
   - Title: Find Specialists  
   - Description: Locate amyloidosis specialists in your area
   - 
   - Link: #specialists

2. Patient Resources Card:
   - 
   - Title: Patient Resources
   - Description: Comprehensive guides for patients and families
   -   
   - Link: #resources

3. Support Groups Card:
   - 
   - Title: Support Groups
   - Description: Connect with others and find support
   - 
   - Link: #support

4. Get Involved Card:
   - 
   - Title: Get Involved
   - Description: Join our community and make a difference  
   - 
   - Link: #get-involved

5. Events Card:
   - 
   - Title: Events
   - Description: Upcoming events and meetings
   - 
   - Link: #events

6. Contact Us Card:
   - 
   - Title: Contact Us
   - Description: Get in touch with our team
   - 
   - Link: #contact

--- EVENTS & NEWSLETTER SECTION ---
Badge: Stay Connected
Title: Events & Newsletter
Subtitle: Stay informed about the latest research, treatment advances, and community events in amyloidosis care.

Layout: Header with logo, 3 event cards, then community stats and newsletter signup

CAS Logo Display:
- Canadian Amyloidosis Society logo image with 

Event Cards (3 cards):
1. Patient & Family Conference:
   - 
   - Title: Patient & Family Conference
   - Description: Annual gathering featuring leading specialists and patient advocates sharing the latest advances in treatment and care.
   - Date: November 15-16, 2024  
   - Attendees: 250+
   - Type: In-Person
   - 
   

2. Monthly Research Webinars:
   - 
   - Title: Monthly Research Webinars
   - Description: Expert presentations on the latest treatment advances, diagnostic techniques, and clinical trial updates.
   - Date: First Thursday of each month
   - Attendees: 500+
   - Type: Virtual
   - 
   

3. Support Group Meetings:
   - 
   - Title: Support Group Meetings
   - Description: Virtual and in-person meetings across Canada providing emotional support and practical guidance.
   - Date: Weekly sessions available
   - Attendees: 50+
   - Type: Hybrid
   - 
   

--- DIRECTORY PREVIEW SECTION ---
Badge: Find Care
Title: Find Specialized Care  
Subtitle: Connecting healthcare across the nation.

Layout: Header, Interactive Map, Feature Cards, Statistics

Interactive Canada Map:
- Compact map display (h-64 md:h-80)
- Healthcare center markers with clustering
- Clickable provinces showing center details
- Color-coded legend for center types
- Hover tooltips with province names

Directory Features (4 cards):
1. Treatment Centers:
   - 
   - Title: Treatment Centers
   - Description: Specialized amyloidosis treatment facilities across Canada
   - 

2. Clinical Experts:
   -   
   - Title: Clinical Experts
   - Description: Leading physicians and healthcare professionals
   - 

3. Support Networks:
   - 
   - Title: Support Networks
   - Description: Patient advocacy groups and community resources
   - 

4. Resources Library:
   - 
   - Title: Resources Library
   - Description: Medical protocols and educational materials
   - 

Quick Statistics (3 cards):
1. "1.2K+" | "Active Patients" | 
2. "45+" | "Research Studies" |   
3. "8" | "Clinical Trials" | 

Map Legend:
- Hospitals (blue markers)
- Specialty Centers (green markers)  
- Research Centers (purple markers)
- Clinics (orange markers)
- Connecting healthcare across the nation

Map Legend:
- 10+ Centers (Blue)
- 5-9 Centers (Green) 
- 2-4 Centers (Light Blue)
- 1 Center (Orange)

Network Stats:
- Total Healthcare Centers
- Active Provinces
- Total Provinces & Territories

--- EVENTS & NEWSLETTER SECTION ---
Badge: Stay Connected
Title: Events & Newsletter
Subtitle: Stay informed about the latest research, treatment advances, and community events in amyloidosis care.

Description: Join our community to receive regular updates, educational content, and information about upcoming events, webinars, and support group meetings.

Features:
- Upcoming Events
- Latest News & Updates
- Newsletter Signup
- Email: Enter your email address
- Button: Subscribe to Newsletter

Stay Connected:
- Join Our Community
- Get exclusive access to research updates, community events, and expert insights delivered monthly.
- Join 5,000+ community members

Statistics:
- Subscribers
- Events/Year
- Provinces
- Satisfaction

Community Calendar:
- Community Calendar
- Connect with experts, patients, and researchers through our comprehensive event program.

--- QUICK LINKS SECTION ---
Badge: Quick Access
Title: Essential Resources
Subtitle: Quick access to the most important tools and information for patients, families, and healthcare professionals.

Six Quick Links:

1. Patient Resources
   - Comprehensive guides for patients and families
   - Button: Get Access

2. Healthcare Directory
   - Specialized centers and experts
   - Button: Browse

3. Support Groups
   - Connect with others and find support
   - Button: Connect

4. Research Updates
   - Latest advances and research
   - Button: Stay Informed

5. Emergency Contacts
   - Urgent help resources
   - Button: Get Help

6. Clinical Trials
   - Research participation opportunities
   - Button: Explore

Additional Quick Actions:
- Find Specialists: Locate amyloidosis specialists in your area
- Get Involved: Join our community and make a difference
- Button: Access Now
- Events: Upcoming events and meetings
- Contact Us: Get in touch with our team
- Status: Available

--- FEATURED SPOTLIGHTS SECTION ---
Badge: Featured
Title: Featured Spotlights
Subtitle: Latest updates, success stories, and amyloidosis research breakthroughs from our community.

Content Categories:
- Latest News
- Patient Stories  
- Research Updates
- Button: Read More
- Button: View All

Content Types:
- Author
- Date
- Category
- Button: Share Story
- News Updates
- Research Highlights
- Community News
- Patient Journey
- Treatment Breakthrough
- Diagnostic Improvement

================================================================================
2. ABOUT CAS PAGE (/about)
================================================================================

--- HERO SECTION ---
Badge: About CAS
Title: Canadian Amyloidosis Society
Subtitle: Connecting Healthcare Across Canada
Description: Building a national platform for clinical practice support
Extended Description: Founded by healthcare professionals for healthcare professionals. We unite clinicians, researchers, and institutions to advance amyloidosis care through evidence-based collaboration.

Buttons:
- Our Mission
- Get Involved

Statistics:
- Healthcare Professionals
- Partner Institutions
- Clinical Resources
- Provinces/Territories

--- WHAT WE DO SECTION ---
Title: What We Do

Three Core Areas:

1. Tool Curation
   - Evidence-based clinical tools, protocols, and diagnostic pathways developed by practicing specialists.

2. Diagnostic Support
   - Rapid diagnostic pathways, decision support tools, and consultation networks for complex cases.

3. Peer Learning
   - Collaborative professional networks, case discussions, and continuous medical education opportunities.

--- VALUES SECTION ---
Four Core Values:

1. Patient-Centered
   - Every decision and resource is designed with patient outcomes as the primary focus.

2. Collaborative
   - We bring together diverse expertise to solve complex clinical challenges.

3. Evidence-Informed
   - All resources are grounded in current research and clinical best practices.

4. Transparent
   - Open access to information, clear governance, and accountable stewardship.

--- SERVICES SECTION ---
Services Offered:
- Comprehensive healthcare provider directory
- Rapid diagnostic pathway tools
- Clinical information resources
- Professional development materials
- Expert committee guidance

--- EXECUTIVE COMMITTEE SECTION ---
Title: Executive Committee
Subtitle: Leading healthcare professionals dedicated to advancing amyloidosis care

Committee Members:
- Dr. Sarah Chen - Medical Director
- Dr. Michael Thompson - Clinical Research Lead
- Dr. Jennifer Walsh - Patient Care Coordinator
- Dr. David Kumar - Technology Integration
- Dr. Lisa Martinez - Community Outreach
- Dr. Robert Fraser - Quality Assurance

Join Our Clinical Network:
Title: Join Our Clinical Network
Subtitle: Contribute to advancing amyloidosis care in Canada
Description: Whether you're a clinician, researcher, or healthcare professional, there are multiple ways to contribute to our mission.

Three Contribution Paths:

1. Clinician Contributors
   - Share expertise through case studies, tool validation, and peer review.

2. Research Collaborators
   - Contribute to evidence base through studies, publications, and data sharing.

3. Institutional Partners
   - Healthcare organizations supporting infrastructure and resources.

--- GOVERNANCE DOCUMENTS SECTION ---
Title: Governance & Documents
Subtitle: Transparent governance and organizational documents

Three Document Categories:

1. Corporate Governance
   - Articles of incorporation, by-laws, and board meeting minutes.
   Documents: Annual Financial Report, Audit Results, Funding Sources, Impact Metrics

2. Financial Transparency
   - Annual financial reports, audited statements, and funding sources.

3. Clinical Governance
   - Evidence review processes, clinical advisory guidelines, and quality standards.

Buttons:
- Download Document
- View Document

--- STRATEGIC PARTNERSHIPS SECTION ---
Title: Strategic Partnerships
Subtitle: Collaborative relationships that strengthen our impact
Description: We work with leading organizations to advance amyloidosis care, research, and patient support across Canada and internationally.

Buttons:
- Contact Us
- Learn More
- View All Partnerships

Final CTAs:
- Join Our Network
- Get Involved
- Explore Resources

================================================================================
3. ABOUT AMYLOIDOSIS PAGE (/about-amyloidosis)
================================================================================

--- HERO SECTION ---
Badge: Medical Information
Title: Understanding Amyloidosis
Subtitle: Learn the signs, understand the types, and take action early.
Description: Amyloidosis is a rare but serious disease where misfolded proteins accumulate in organs. Early detection and appropriate treatment can significantly improve outcomes.
Target Audience: PCPs, cardiologists, neurologists, nephrologists, hematologists
Buttons: Get Started, Browse Directory

--- SIMPLIFIED PATHOPHYSIOLOGY SECTION ---
Title: Pathophysiology
Description: Amyloidosis occurs when proteins misfold and accumulate in tissues.
Detailed Explanation: When proteins misfold, they can form fibril deposits called amyloid that accumulate in various organs and tissues, disrupting normal function and potentially leading to organ failure if left untreated.

--- WARNING SIGNS SECTION ---
Title: Warning Signs
Subtitle: Early symptoms that require medical attention.

Five Symptom Categories:

1. Cardiac Symptoms:
   
   Symptoms:
   - Shortness of breath
   - Chest pain  
   - Irregular heartbeat
   - Swelling in legs/ankles
   - Fatigue during normal activities

2. Neurological Symptoms:
   
   Symptoms:
   - Numbness in hands/feet
   - Tingling sensations
   - Muscle weakness
   - Carpal tunnel syndrome
   - Balance problems

3. Gastrointestinal Symptoms:
   
   Symptoms:
   - Persistent diarrhea
   - Nausea and vomiting
   - Abdominal pain
   - Loss of appetite
   - Malabsorption symptoms

4. Genitourinary Symptoms:
   
   Symptoms:
   - Proteinuria (protein in urine)
   - Decreased urine output
   - Kidney dysfunction
   - Urinary retention
   - Bladder problems

5. Systemic Symptoms:
   
   Symptoms:
   - Unexplained weight loss
   - Enlarged tongue
   - Easy bruising
   - Changes in skin texture
   - Chronic fatigue

--- TYPES OF AMYLOIDOSIS SECTION ---
Title: Types of Amyloidosis
Subtitle: Major forms and their characteristics.

Three Expandable Type Cards:

1. AL (Light-Chain) Amyloidosis:
   Subtitle: Caused by abnormal plasma cells producing light chains
   Prevalence: Often diagnosed after age 50; affects both men and women
   Disease Context: Related to multiple myeloma (10-15% overlap)
   
   Symptoms:
   - Leg swelling
   - Fatigue
   - Irregular heartbeat
   - Enlarged tongue
   - Skin changes (bruising, purple patches around eyes)
   
   Diagnosis Methods:
   - Tissue biopsy
   - Blood/urine tests for light chains
   - Bone marrow biopsy
   - Imaging tests (ECG, MRI, echocardiogram)
   
   Treatment Options:
   - Chemotherapy
   - Steroids
   - Proteasome inhibitors
   - Monoclonal antibodies
   - Stem cell transplant (in select cases)
   - Supportive care to manage symptoms and organ function
   
   Key Point: Target abnormal plasma cells with various therapies

2. ATTR (Transthyretin) Amyloidosis:
   Subtitle: Two forms: Hereditary (hATTR) and Wild-type (ATTRwt)
   Prevalence: hATTR: Over 120 TTR mutations known
   Disease Context: ATTRwt: Non-inherited, develops with age, primarily affects men over 60
   
   Symptoms:
   - Heart issues: palpitations, fainting, fatigue
   - Nerve issues: numbness, walking difficulty
   - GI symptoms: nausea, weight loss
   
   Diagnosis Methods:
   - Genetic testing for TTR mutations
   - Biopsies, imaging (MRI, scans)
   - Protein testing
   
   Treatment Options:
   - TTR stabilizers: Tafamidis (Vyndaqel), Acoramidis (Attruby)
   - Gene silencers: Patisiran (Onpattro), Vutrisiran (Amvuttra)
   - Supportive care for symptoms and organ protection
   
   Key Point: Wild-type often causes heart failure and carpal tunnel syndrome

3. Rare Types of Amyloidosis:
   Subtitle: AA, ALECT2, Aβ2M, and other rare forms
   Prevalence: Variable prevalence by geographic and ethnic background
   Disease Context: Different underlying causes and affected organs
   
   Symptoms:
   - AA: Linked to long-standing inflammation, mostly affects kidneys
   - ALECT2: More common in Mexican, Punjabi, Native American, Middle Eastern descent
   - Aβ2M: Seen in long-term dialysis patients, affects bones and joints
   
   Diagnosis Methods:
   - Biopsies, blood and urine analysis
   - Imaging: ECG, MRI, echocardiograms
   - Genetic testing for hereditary types
   - Specialized testing: mass spectrometry, immunohistochemistry
   
   Treatment Options:
   - AA: Treat underlying disease to reduce SAA protein
   - ALECT2: Often underdiagnosed, mainly affects kidneys
   - Aβ2M: Becoming rarer due to improved dialysis techniques
   - Supportive care and research ongoing for most types
   
   Key Point: Early diagnosis is critical for better outcomes

--- DIAGNOSTIC PATHWAY SECTION ---
Title: Diagnostic Pathway
Subtitle: Systematic approach to diagnosis.

5-Step Evidence-Based Approach:
1. Clinical suspicion based on symptoms and presentation
2. Initial screening with appropriate blood tests and imaging
3. Confirmatory testing including tissue biopsy
4. Typing studies to determine specific amyloid protein
5. Subtype classification for targeted treatment planning

--- CLINICAL GUIDELINES SECTION ---
Title: Clinical Guidelines
Subtitle: Professional resources for clinicians.

External Resources:
- Canadian Cardiovascular Society (CCS) Guidelines
- Mayo Clinic Protocols  
- NHS Treatment Standards

--- PROFESSIONAL DISCLAIMER SECTION ---
Title: Professional Disclaimer
Content: This information is intended for healthcare professionals and educational purposes. It does not replace professional medical advice.
Emergency Notice: For medical emergencies, call 911

Call-to-Action Buttons:
- Find a Specialist
- Download Resources
- View Complete Directory
- Explore Resources
- Learn more about types
- Access Clinical Tools

================================================================================
4. DIRECTORY PAGE (/directory)
================================================================================

--- HERO SECTION ---
Title: Healthcare Provider Directory
Subtitle: Connect with amyloidosis specialists and treatment centers across Canada
Search Features: Geographic and specialty filtering

--- INTERACTIVE MAP SECTION ---
Province-by-Province Coverage:
- All 13 provinces and territories
- Healthcare center clustering
- Detailed facility information

--- QUALITY ASSURANCE SECTION ---
Title: Directory Standards & Review Process

Directory Standards:

1. Inclusion Criteria:
   - Clinical expertise documentation
   - Specialty services verification
   - Geographic coverage requirements
   - Verified contact information

2. Review Cycle:
   - Quarterly comprehensive reviews
   - Real-time updates
   - Professional verification
   - Community feedback integration

--- BACKEND VETTING PROCESS SECTION ---
Title: Backend Vetting Process

Six-Step Process:
1. Medical license verification
2. Hospital/clinic accreditation check
3. Specialty certification confirmation
4. Annual contact verification
5. Service offering updates
6. Quality assurance reviews

--- DIRECTORY UPDATE SECTION ---
Title: Help us maintain the most comprehensive directory
Subtitle: Help us maintain the most comprehensive directory of amyloidosis care providers. Suggest new clinics or update existing information.

Buttons:
- Suggest a Clinic
- Update Information

================================================================================
5. CONTACT PAGE (/contact)
================================================================================

--- HERO SECTION ---
Title: Contact Us
Subtitle: Get in touch with our team
Description: We're here to help with your questions, resource needs, and collaboration opportunities.

--- CONTACT SECTIONS ---
Four Specialized Contact Areas:

1. General Inquiries
   - Email: info@canadianamyloidosis.ca
   - Phone: 1-800-CAS-INFO
   - Description: Questions about CAS, media requests, or collaboration opportunities
   - Response Time: 24-48 hours

2. Resource & Directory Updates
   - Email: resources@canadianamyloidosis.ca
   - Phone: 1-800-CAS-INFO ext. 2
   - Description: Submit new resources, update directory information, or report issues
   - Response Time: 3-5 business days

3. Membership & Support
   - Email: support@canadianamyloidosis.ca
   - Phone: 1-800-CAS-INFO ext. 3
   - Description: Membership questions, support group information, or volunteer opportunities
   - Response Time: 1-2 business days

4. Healthcare Professionals
   - Email: professionals@canadianamyloidosis.ca
   - Phone: 1-800-CAS-INFO ext. 4
   - Description: Professional resources, collaboration, and educational opportunities
   - Response Time: 2-3 business days

--- CONTACT FORM SECTION ---
Title: Send us a Message
Subtitle: Fill out the form below and we'll get back to you promptly

Form Fields:
- Name
- Email
- Organization (Optional)
- Inquiry Type
- Subject
- Message
- Privacy Consent: I agree to the privacy policy and terms of service
- Security Verification

Inquiry Types:
- General Question
- Resource Request
- Support Needed
- Professional Collaboration
- Media Inquiry
- Other

Buttons:
- Send Message
- Sending...

--- FAQ SECTION ---
Title: Frequently Asked Questions
Subtitle: Quick answers to common questions

Six FAQ Categories:

1. How can I access clinical resources?
   Answer: Healthcare professionals can access our clinical resources through the Resources section. Some materials require registration to ensure appropriate use in clinical settings.

2. Is there a membership fee for CAS?
   Answer: CAS membership is free for all healthcare professionals and researchers. Patient and family access to support resources is also provided at no cost.

3. Do you provide direct patient care?
   Answer: CAS does not provide direct patient care. We connect patients with specialized healthcare providers and provide educational resources to support informed healthcare decisions.

4. How can my organization partner with CAS?
   Answer: We welcome partnerships with healthcare institutions, research organizations, and professional societies. Contact us at professionals@canadianamyloidosis.ca to discuss collaboration opportunities.

5. Can I contribute clinical resources to CAS?
   Answer: Yes! We encourage healthcare professionals to share evidence-based resources. All submissions undergo peer review to ensure clinical accuracy and relevance.

6. How do I stay updated on CAS activities?
   Answer: Join our newsletter, follow our social media channels, or register for our professional network to receive regular updates on research, resources, and events.

--- OFFICE INFORMATION SECTION ---
Title: Office Information

National Office:
- Canadian Amyloidosis Society
- Canada
- Phone: (555) 123-4567
- Email: info@canadianamyloidosis.ca

Office Hours:
- Monday - Friday: 9:00 AM - 5:00 PM EST
- Saturday - Sunday: Closed

Important Notes:
- For medical emergencies, please contact your healthcare provider or call 911
- Services available in English and French
- Response Time varies by inquiry type

================================================================================
6. HEALTHCARE CENTER DATABASE
================================================================================

--- COVERAGE STATISTICS ---
- Total Centers: 25+ facilities
- Provincial Coverage: All 13 provinces/territories
- Center Types: Hospitals, Specialty Centers, Research Facilities, Clinics

--- FACILITY INFORMATION STRUCTURE ---
Standardized Data Points for Each Center:
- Center name and location
- Contact information (phone, email, website, address)
- Specialties and services offered
- Center type and certifications
- Establishment year
- Detailed descriptions

--- MAJOR CENTERS BY PROVINCE ---

BRITISH COLUMBIA (2 centers):
1. Vancouver General Hospital
   - Vancouver, BC
   - Phone: (604) 875-4111
   - Email: amyloidosis@vch.ca
   - Specialties: AL Amyloidosis, ATTR Amyloidosis, Cardiac Amyloidosis
   - Services: Diagnosis, Treatment, Clinical Trials, Cardiac Care
   - Description: Leading comprehensive amyloidosis treatment center in Western Canada with specialized cardiac unit.

2. St. Paul's Hospital
   - Vancouver, BC
   - Phone: (604) 682-2344
   - Email: cardiology@sth.ca
   - Specialties: Cardiac Amyloidosis, Heart Failure
   - Services: Cardiac Assessment, Specialized Imaging, Treatment
   - Description: Specialized cardiac amyloidosis center with advanced imaging capabilities.

ALBERTA (1 center):
1. Foothills Medical Centre
   - Calgary, AB
   - Phone: (403) 944-1110
   - Email: amyloidosis@ahs.ca
   - Specialties: AL Amyloidosis, Multi-organ Care, Hematology
   - Services: Diagnosis, Chemotherapy, Stem Cell Transplant, Monitoring
   - Description: Alberta's primary amyloidosis treatment center with comprehensive care.

ONTARIO (4 centers):
1. Toronto General Hospital
   - Toronto, ON
   - Phone: (416) 340-4800
   - Email: amyloidosis@uhn.ca
   - Specialties: AL Amyloidosis, ATTR Amyloidosis, Cardiac Amyloidosis
   - Services: Comprehensive Care, Transplant, Research, Clinical Trials
   - Description: Canada's largest amyloidosis program with comprehensive multidisciplinary care.

2. Princess Margaret Cancer Centre
   - Toronto, ON
   - Phone: (416) 946-4501
   - Email: hematology@uhn.ca
   - Specialties: AL Amyloidosis, Hematology, Stem Cell Transplant
   - Services: Hematology, Stem Cell Transplant, Clinical Trials
   - Description: Leading cancer center specializing in AL amyloidosis treatment.

3. University of Ottawa Heart Institute
   - Ottawa, ON
   - Phone: (613) 696-7000
   - Email: cardiology@ottawaheart.ca
   - Specialties: Cardiac Amyloidosis, ATTR Amyloidosis
   - Services: Cardiac Assessment, Specialized Imaging, Treatment
   - Description: Specialized cardiac amyloidosis center with advanced diagnostic capabilities.

4. Hamilton General Hospital
   - Hamilton, ON
   - Phone: (905) 527-4322
   - Email: nephrology@hhsc.ca
   - Specialties: AL Amyloidosis, Nephrology
   - Services: Diagnosis, Treatment, Kidney Care
   - Description: Regional amyloidosis center serving southwestern Ontario.

QUEBEC (3 centers):
1. Montreal Heart Institute
   - Montreal, QC
   - Phone: (514) 376-3330
   - Email: amyloidosis@icm-mhi.org
   - Specialties: Cardiac Amyloidosis, ATTR Amyloidosis, Research
   - Services: Cardiac Care, Research, Clinical Trials, Genetic Testing
   - Description: Leading cardiac amyloidosis research and treatment center in Quebec.

2. Centre Hospitalier de l'Université de Montréal
   - Montreal, QC
   - Phone: (514) 890-8000
   - Email: hematologie@chum.qc.ca
   - Specialties: AL Amyloidosis, Hematology
   - Services: Hematology, Diagnosis, Treatment
   - Description: University hospital with specialized hematology-oncology amyloidosis program.

3. Institut Universitaire de Cardiologie et de Pneumologie de Québec
   - Quebec City, QC
   - Phone: (418) 656-8711
   - Email: cardiologie@criucpq.ulaval.ca
   - Specialties: Cardiac Amyloidosis, Pulmonary Care
   - Services: Cardiac Care, Pulmonary Assessment, Treatment
   - Description: Specialized cardiac and pulmonary amyloidosis program.

[Additional provinces have 1-2 centers each with similar detailed information]

================================================================================
7. NAVIGATION & FOOTER CONTENT
================================================================================

--- MAIN NAVIGATION ---
Primary Navigation Links:
- Home
- About
- Resources
- Directory
- Community
- Contact

Dropdown Menus:
About:
- About CAS
- About Amyloidosis
- Governance
- Accessibility Statement

Resources:
- Browse Resources
- Upload Resource
- Resource Moderation

Community:
- Get Involved
- Join CAS
- Join CANN
- Events

--- FOOTER CONTENT ---
Four-Column Layout:

1. Quick Links:
- Home
- About CAS
- About Amyloidosis
- Resources
- Directory
- Contact
- Get Involved
- Accessibility

2. Contact Information:
- Phone: 1-800-CAS-INFO
- Email: info@canadianamyloidosis.ca
- National Office
- Available in English and French

3. Legal & Privacy:
- Privacy Policy
- Terms of Use
- Accessibility Statement
- Cookie Policy

4. Language Status:
- English: Available
- French: Available
- Bilingual Support Indicators

Social Media Links:
- Professional networking platforms
- Educational resource channels
- Community engagement tools

Copyright: © 2025 Canadian Amyloidosis Society. All rights reserved.

================================================================================
8. AMYLOIDOSIS TYPE DETAIL PAGES
================================================================================

--- AL AMYLOIDOSIS PAGE (/amyloidosis-types/al) ---
Title: AL Amyloidosis (Light Chain)
Focus Areas:
- Cardiac involvement patterns
- Treatment protocols
- Prognosis factors
- Clinical statistics
- Hematologic origin details
- Multi-organ involvement patterns

--- ATTR AMYLOIDOSIS PAGE (/amyloidosis-types/attr) ---
Title: ATTR Amyloidosis (Transthyretin)
Content Sections:
- Genetic vs. wild-type variants
- Neurologic manifestations
- Cardiac complications
- Therapeutic approaches
- Hereditary patterns
- Treatment options

--- OTHER AMYLOIDOSIS TYPES PAGE (/amyloidosis-types/other) ---
Title: Other & Rare Amyloidosis Types
Comprehensive Coverage:
- AA Amyloidosis characteristics
- Localized amyloidosis forms
- Dialysis-related complications
- Rare variant presentations
- Secondary amyloidosis types
- Regional manifestations

================================================================================
9. ACCESSIBILITY FEATURES TEXT
================================================================================

--- ACCESSIBILITY TOOLS ---
WCAG 2.1 Level AA Compliance Features:
- Font size adjustment (12px-24px)
- High contrast modes (Normal, High Contrast, Inverted)
- Cursor size options (Normal, Large, Extra-Large)
- Reduced motion support
- Dyslexia-friendly fonts (OpenDyslexic option)
- Screen reader optimization

--- ACCESSIBILITY STATEMENT PAGE ---
Title: Accessibility Statement
Content: Comprehensive accessibility statement with compliance details, features, and contact information for accessibility support.

Keyboard Navigation Features:
- Skip links implementation
- Focus indicators throughout site
- Semantic HTML structure
- ARIA labels and announcements
- Full keyboard accessibility

================================================================================
10. LANGUAGE SUPPORT CONTENT
================================================================================

--- BILINGUAL IMPLEMENTATION ---
Primary Language: English (fully implemented)
Secondary Language: French (comprehensive translation system)

Translation Coverage Areas:
- All major content sections
- User interface elements
- Form labels and validation messages
- Navigation and menu items
- Error messages and notifications
- Modal dialogs and popups
- Button text and calls-to-action

Language Status Indicators:
- "Available" tags for completed translations
- "Coming Soon" tags for content in development
- Persistent language switcher in footer
- localStorage-based language preference saving

--- FRENCH TRANSLATIONS ---
Hero Section (French):
Main Title: Société Canadienne d'Amyloïdose (SCA)
Subtitle: Accélérer la sensibilisation, faire progresser les soins et soutenir les patients à travers le Canada grâce à des ressources fondées sur des preuves et une collaboration professionnelle.

[Comprehensive French translations available for all major sections]

================================================================================
END OF CONTENT DOCUMENTATION
================================================================================

Total Translation Keys: 200+
Total Healthcare Centers: 25+
Provincial Coverage: 13 provinces and territories
Language Support: English (complete) and French (comprehensive)
Accessibility Compliance: WCAG 2.1 Level AA
Brand Colors:  (blue) and  (green)
Typography: Rosarivo (headings) and Mulish (body text)

This document contains all text content used across the Canadian Amyloidosis Society website as of July 2025.